PNPLA3 and hepatocellular carcinoma: However, the implications of PNPLA3 genotype for patients already diagnoses with HCC are still unknown, as only preliminary and controversial data are available on the influence of I148M polymorphism on the clinical presentation and outcome of HCC [9], [22].